| 1 (72) | Regeneron Pharmaceuticals Inc | USA |  |
| 2 (110) | Sanofi, United States | USA | |
| 3 (120) | AstraZeneca, Sweden | SWE | |
| 4 (137) | Siemens AG, USA | USA | |
| 5 (145) | Siemens AG, Germany | DEU | |
| 6 (179) | Amgen, USA | USA | |
| 7 (199) | Siemens Healthineers, USA | USA | |
| 8 (206) | Novartis, Switzerland | CHE | |
| 9 (225) | Bristol-Myers Squibb Company, United States | USA | |
| 10 (238) | Janssen Biotech Inc | USA | |
| 11 (242) | Merck & Co Inc, United States | USA | |
| 12 (246) | Bayer AG, Germany | DEU | |
| 13 (307) | Novartis Pharmaceuticals, United States | USA | |
| 14 (310) | Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique | FRA | |
| 15 (396) | Boehringer Ingelheim, USA | USA | |
| 16 (415) | Boehringer Ingelheim GmbH Germany | DEU | |
| 17 (464) | Eli Lilly and Company, United States | USA | |
| 18 (509) | AstraZeneca, United Kingdom | GBR | |
| 19 (524) | Novo Nordisk A/S | DNK | |
| 20 (569) | AstraZeneca, United States | USA | |
| 21 (576) | Pfizer Inc, United States | USA | |
| 22 (639) | Daiichi Sankyo Co., Ltd. Japan | JPN | |
|
